Professor Billy Hargis determines numbers of disease-causing bacteria from the intestinal tracts of chickens treated or untreated with direct-fed microbials under development at the University of Arkansas Division of Agriculture’s Poultry Health Laboratory.
(Photo: Submitted)
FAYETTEVILLE, Ark. – A few years ago Billy Hargis’s poultry research
laboratory found how to develop probiotics – also known as direct-fed
microbials (DFMs) – that would work in the drinking water of chickens and
turkeys to fight Salmonella. One of
their DFM products was designated as FM-B11 and was licensed to a startup
company. It then became a product called FloraMax. It was clear, however, that
going to the next level was necessary.
Hargis,
director of the University of Arkansas Division of Agriculture Poultry Health
Research Laboratory, explained that FloraMax has been successful as a drinking
water treatment to reduce the Salmonella
levels in birds and ultimately on carcasses at processing. Performance, a
crucial component for the poultry industry as it determines how to allocate its
dollars, is difficult to measure. In published research, Hargis’ team has shown
that meaningful improvements in production efficiency occurred with this DFM
product. Problematic for some
poultry producers was that FloraMax must be administered in the drinking water
because it is not stable in feed. Hargis and his research team continued their project, funded by the Food
Safety Consortium, and turned to development of new DFMs using bacteria from
the Bacillus genus. Some Bacillus isolates produce heat-resistant
spores that could potentially be used in feed milling with easy and continuous
administration in poultry feed.
Fighting foodborne pathogens is always the main focus of the research,
but Hargis knows there are other factors that dictate whether the research will
be applicable. “We also realize
that unless there’s an economic incentive to use this approach other than just
the control of foodborne pathogens, there is going to be very limited use,” he
said.
DFMs are beginning to be used frequently in animal feed as an
alternative to antibiotics and serve as growth promoters. For several years,
interest has risen in developing new DFMs that are safe for use in animal feeds
and effective for both performance enhancement and reduction of foodborne
disease-causing bacteria. Such efforts led Hargis and his team to develop what
ultimately was named FloraMax.
While that was a successful venture, Hargis noted, “there is still an
increased need to have highly effective DFMs that are shelf-stable,
cost-effective and feed stable (tolerance to the heat pelletization process) to
increase compliance and widespread utilization.”
Bacterial spore formers from the genus Bacillus are among the DFM products being developed. Coming from
specially selected spores, the resulting probiotic products can be stored
indefinitely on the shelf and survive the extreme heat treatment of commercial
poultry feed, Hargis said.
The research at the University of Arkansas poultry health lab has identified a combination
of spore isolates from Bacillus
species that are as effective as FM-B11 at reducing Salmonella enteritidis in chickens and turkeys. It’s a major step.
“The ability to grow Bacillus
to huge numbers of stable and cost-effective spores that can decrease
pathogenic bacteria will have a tremendous impact on broiler health and
productivity,” Hargis said.
The
economic impact of using spore-derived DFMs can provide a financial advantage
for industry along with the ability to improve food safety. That’s why the
Hargis research team discarded spore isolates if they didn’t grow to large
numbers in inexpensive media.
Hargis
explained that the cost of reducing Salmonella
creates an incentive for industry to seek ways to do so efficiently.
“If
we can reduce the pathogens that cost the producer money, then it adds value to
the approach of using DFMs,” he said. “That may be part of the key to
accomplishing the goal of reducing pathogens in food that comes from poultry
and reducing pathogens capable of causing human foodborne illness in live
poultry. We’ve got to give them a return on their investment.”
It
is essential, Hargis said, is that the product be developed at a cost that
won’t discourage its use. Finding spore isolates for feed that are capable of
reducing Salmonella and other
pathogens in poultry has the potential of doing the job.
“Now
we may have something that we actually do in the real world that makes food
safer and that companies are willing to pay for,” Hargis said. “We’re looking
to do something and trying to achieve some results. If this was easy, it would
have been done before.”